Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses
Phelps, M A, Stinchcombe, T E, Blachly, J S, Zhao, W, Schaaf, L J, Starrett, S L, Wei, L, Poi, M, Wang, D, Papp, A, Aimiuwu, J, Gao, Y, Li, J, Otterson, G A, Hicks, W J, Socinski, M A, Villalona-Calero, M A
Published in Clinical pharmacology and therapeutics (01.08.2014)
Published in Clinical pharmacology and therapeutics (01.08.2014)
Get more information
Journal Article
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
Rothenberg, M L, Eckardt, J R, Kuhn, J G, Burris, 3rd, H A, Nelson, J, Hilsenbeck, S G, Rodriguez, G I, Thurman, A M, Smith, L S, Eckhardt, S G, Weiss, G R, Elfring, G L, Rinaldi, D A, Schaaf, L J, Von Hoff, D D
Published in Journal of clinical oncology (01.04.1996)
Published in Journal of clinical oncology (01.04.1996)
Get more information
Journal Article
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
SLATTER, J. G, SCHAAF, L. J, MILLER, L. L, BAKER, D. S, PESHECK, C. V, LORD, R. S, SAMS, J. P, FEENSTRA, K. L, JOHNSON, M. G, BOMBARDT, P. A, CATHCART, K. S, VERBURG, M. T, PEARSON, L. K, COMPTON, L. D
Published in Drug metabolism and disposition (01.04.2000)
Get full text
Published in Drug metabolism and disposition (01.04.2000)
Journal Article
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
Xu, Y, Kolesar, J. M, Schaaf, L. J, Drengler, R, Duan, W, Otterson, G, Shapiro, C, Kuhn, J, Villalona-Calero, M. A
Published in Cancer chemotherapy and pharmacology (01.05.2009)
Published in Cancer chemotherapy and pharmacology (01.05.2009)
Get full text
Journal Article
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions
SLATTER, J. G, SU, P, SAMS, J. P, SCHAAF, L. J, WIENKERS, L. C
Published in Drug metabolism and disposition (01.10.1997)
Get full text
Published in Drug metabolism and disposition (01.10.1997)
Journal Article
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
Rothenberg, M. L., Kuhn, J. G., Schaaf, L. J., Rodriguez, G.I., Eckhardt, S. G., Villalona-Calero, M. A., Rinaldi, D. A., Hammond, L. A., Hodges, S., Sharma, A., Elfring, G. L., Petit, R. G., Locker, P. K., Miller, L. L., von Hoff, D. D.
Published in Annals of oncology (01.11.2001)
Published in Annals of oncology (01.11.2001)
Get full text
Journal Article
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors
Saltz, L B, Spriggs, D, Schaaf, L J, Schwartz, G K, Ilson, D, Kemeny, N, Kanowitz, J, Steger, C, Eng, M, Albanese, P, Semple, D, Hanover, C K, Elfring, G L, Miller, L L, Kelsen, D
Published in Journal of clinical oncology (01.12.1998)
Published in Journal of clinical oncology (01.12.1998)
Get more information
Journal Article
Phase II Study of Irinotecan Plus Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer
DEVORE, R. F, JOHNSON, D. H, MILLER, L. L, CRAWFORD, J, GARST, J, DIMERY, I. W, ECKARDT, J, ECKHARDT, S. G, ELFRING, G. L, SCHAAF, L. J, HANOVER, C. K
Published in Journal of clinical oncology (01.09.1999)
Published in Journal of clinical oncology (01.09.1999)
Get full text
Journal Article
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
BLUM, William, PHELPS, Mitch A, JOHNSON, Amy, SCHAAF, Larry J, BYRD, John C, MARCUCCI, Guido, GREVER, Michael R, KLISOVIC, Rebecca B, ROZEWSKI, Darlene M, WENJUN NI, ALBANESE, Katie A, ROVIN, Brad, KEFAUVER, Cheryl, DEVINE, Steven M, LUCAS, David M
Published in Haematologica (Roma) (01.07.2010)
Published in Haematologica (Roma) (01.07.2010)
Get full text
Journal Article
Irinotecan Therapy in Adults With Recurrent or Progressive Malignant Glioma
FRIEDMAN, H. S, PETROS, W. P, CLOUGHSEY, T, STEWART, E. S, COLVIN, O. M, PROVENZALE, J. M, MCLENDON, R. E, BIGNER, D. D, COKGOR, L, HAGLUND, M, RICH, J, ASHLEY, D, FRIEDMAN, A. H, MALCZYN, J, ELFRING, G. L, MILLER, L. L, SCHAAF, L. J, KERBY, T, LAWYER, J, PARRY, M, HOUGHTON, P. J, LOVELL, S, RASHEED, K
Published in Journal of clinical oncology (01.05.1999)
Published in Journal of clinical oncology (01.05.1999)
Get full text
Journal Article
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
VAN TELLINGEN, O, PUNT, C. J. A, AWADA, A, WAGENER, D. J. T, PICCART, M. J, GROOT, Y, SCHAAF, L. J, HENRAR, R. E. C, NOOIJEN, W. J, BEIJNEN, J. H
Published in Cancer chemotherapy and pharmacology (1998)
Published in Cancer chemotherapy and pharmacology (1998)
Get full text
Journal Article
Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans
VAN TELLINGEN, O, NOOIJEN, W. J, SCHAAF, L. J, VAN DER VALK, M, VAN ASPEREN, J, HENRAR, R. E. C, BEIJNEN, J. H
Published in Cancer research (Chicago, Ill.) (01.06.1998)
Get full text
Published in Cancer research (Chicago, Ill.) (01.06.1998)
Journal Article
Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices
Strong, M L, Schaaf, L J, Pankaskie, M C, Robinson, D H
Published in Journal of clinical pharmacy and therapeutics (01.12.1994)
Published in Journal of clinical pharmacy and therapeutics (01.12.1994)
Get more information
Journal Article
Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors
DRENGLER, R. L, KUHN, J. G, ELFRING, G. L, LOCKER, P. K, MILLER, L. L, VON HOFF, D. D, ROTHENBERG, M. L, SCHAAF, L. J, RODRIGUEZ, G. I, VILLALONA-CALERO, M. A, HAMMOND, L. A, STEPHENSON, J. A, HODGES, S, KRAYNAK, M. A, STATON, B. A
Published in Journal of clinical oncology (01.02.1999)
Published in Journal of clinical oncology (01.02.1999)
Get full text
Journal Article
Phase I Dose-finding and Pharmacokinetic Trial of Irinotecan Hydrochloride (CPT-11) Using a Once-Every-Three-Week Dosing Schedule for Patients with Advanced Solid Tumor Malignancy
Pitot, H C, Goldberg, R M, Reid, J M, Sloan, J A, Skaff, P A, Erlichman, C, Rubin, J, Burch, P A, Adjei, A A, Alberts, S A, Schaaf, L J, Elfring, G, Miller, L L
Published in Clinical cancer research (01.06.2000)
Get full text
Published in Clinical cancer research (01.06.2000)
Journal Article
Irinotecan in the treatment of glioma patients. Current and future studies of the north central cancer treatment group
BUCKNER, Jan C, REID, Joel M, WRIGHT, Keith, KAUFMANN, Scott H, ERLICHMAN, Charles, AMES, Matthew, CHA, Steve, O'FALLON, Judith R, SCHAAF, Lawrence J, MILLER, Langdon L
Published in Cancer (01.05.2003)
Published in Cancer (01.05.2003)
Get full text
Conference Proceeding
Journal Article